- Report
- October 2024
- 199 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- October 2024
- 194 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- December 2021
- 76 Pages
United States
From €5415EUR$5,950USD£4,642GBP
- Report
- January 2022
- 120 Pages
Global
From €4323EUR$4,750USD£3,706GBP
The Long Acting Contraception market is a subset of the Personal Care Products industry. It includes a variety of products designed to provide long-term contraception, such as intrauterine devices (IUDs), contraceptive implants, and injectable contraceptives. These products are designed to provide a safe and effective form of contraception for women who wish to avoid pregnancy.
Long Acting Contraception products are typically used by women who are looking for a more reliable form of contraception than traditional methods, such as the pill or condoms. They are also used by women who are looking for a more convenient form of contraception, as they do not require daily or weekly use.
The Long Acting Contraception market is highly competitive, with a number of companies offering products. Some of the major players in the market include Bayer, Merck, Allergan, and Teva Pharmaceuticals. These companies offer a variety of products, ranging from IUDs to contraceptive implants and injectable contraceptives. Show Less Read more